INTRACARDIAC THROMBOSIS IN CHRONIC HEART FAILURE CHILDREN WITH CARDIOMYOPATHY WITH DILATED PHENOTYPE
Systolic dysfunction and dilatation of the left ventricle in cardiomyopathy patients contribute to the formation of intracardiac thrombosis, especially against the background of hypercoagulation. To determine the predictors of thrombotic complications and the incidence of intracardiac thrombosis in chronic heart failure patients suffered from cardiomyopathy with dilated phenotype there were examined 100 children aged from 1 month to 18 years. In all patients, there was made an assessment of indices of the hemostasis system, molecular genetic examination, including studies of polymorphic markers of hemostasis system genes, as well as folate cycle genes by the method of polymerase chain reaction (real-time). It was established that thrombosis was observed in 11% of children with a 2B-3 stage of heart failure clinic and a functional class (FC) of 3-4, a systolic dysfunction with an ejection fraction below 40% against the background of hypercoagulation of the plasma link of hemostasis. Analysis of genetic markers showed that risk of thrombotic complications to be 5 times higher for carriers of the pathological allele A of the FII gene among chronic heart failure patients suffered from cardiomyopathy with a dilated phenotype. Patients with severe systolic dysfunction have been prescribed prophylactic antithrombotic therapy to achieve an adequate therapeutic range (for anti-Xa factor activity and platelet hypoaggregation).
About the authorsDerevnina Yuliya V.
Jammal Addin MB, Young D, McCarrison S, Hunter L. Dilated cardiomyopathy in a national paediatric population. Eur J Pediatr. 2019. doi: 10.1007/s00431-019-03404-w.
Chen K, Williams S, Chan AK, Mondal TK. Thrombosis and embolism in pediatric cardiomyopathy. Blood Coagul Fibrinolysis. 2013; 24(3): 221-30. doi: 10.1097/MBC.0b013e32835bfd85.
Barberato MF, Barberato SH. Foetal dilated cardiomyopathy with left ventricular thrombosis. Cardiol Young. 2015; 25(6): 1191-2. doi: 10.1017/S104795111500027X.
Bakalli A, Georgievska-Ismail L, Koçinaj D, Musliu N, Krasniqi A, Pllana E. Prevalence of left chamber cardiac thrombi in patients with dilated left ventricle at sinus rhythm: the role of transesophageal echocardiography. J ClinUltrasound. 2013; 41: 38-45.
Bakalli A, Kamberi L, Pllana E, Zahiti B, Dragusha G, Brovina A. The influence of left ventricular diameter on left atrial appendage size and thrombus formation in patients with dilated cardiomyopathy. Turk Kardiyol Dern Ars. 2010; 38: 90- 4.
Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective followup study. Am Heart J. 1992; 123: 136-42.
Jefferies J.L., Wilkinson J.D., Sleeper L.A., Colan S.D., Lu M., Pahl E. et al. Pediatric Cardiomyopathy Registry Investigators. Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. J Card Fail. 2015; 21(11): 877-84.
Basargina E.N., Umarova M.K., Savost’yanov K.V., Derevnina Yu.V., Smirnov I.E. The frequency of thrombotic complications and features of genotypes of polymorphic markers of hemostatic genes in children with noncompact cardiomyopathy. Rossiyskiy pediatricheskiy zhurnal. 2017; 20(3): 139-44. DOI: 10.18821/1560-9561-2017-20-3-139-144. (In Russian)
Umarova M.K., Basargina E.N., Smirnov I.E. Left ventricular noncompaction in children: clinical manifestations and prognosis. Rossiyskiy pediatricheskiy zhurnal. 2016; 19(3): 174-82. (In Russian). DOI: 10.18821/1560-9561-2016-19-3-174-182
Komarova N.L., Sidenko A.V., Smirnov I.E., Basargina E.N., Fedorova N.V. et al. Perfusion myocardial scintigraphy in various forms of heart disease in children. Rossiyskiy pediatricheskiy zhurnal. 2017; 20(6): 364-71. (In Russian). DOI: 10.18821/1560-9561-2017-20-6-364-371
Dal Ferro M, Stolfo D, Altinier A, Gigli M, Perrieri M, Ramani F et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart. 2017; 103(21): 1704-10. doi: 10.1136/heartjnl-2016-311017.
Kayvanpour E, Sedaghat-Hamedani F, Amr A, Lai A, Haas J, Holzer DB et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin Res Cardiol. 2017; 106(2): 127-39. doi: 10.1007/s00392-016-1033-6.
Verdonschot JAJ, Hazebroek MR, Wang P, Sanders-van Wijk S, Merken JJ, Adriaansen YA. et al. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy. Circ Heart Fail. 2018; 11(11): doi: 10.1161/Circheartfailure.118.005220.
Dziewięcka E, Wiśniowska-Śmiałek S, Khachatryan L, Karabinowska A, Szymonowicz M, Podolec P et al. Relationships between left ventricular geometry (sphericity index) and remodeling in dilated cardiomyopathy. Minerva Cardioangiol. 2019. doi: 10.23736/S0026-4725.19.04856-4.
Reichart D, Magnussen C, Zeller T, Blankenberg S. Dilated Cardiomyopathy - From Epidemiologic to Genetic Phenotypes A Translational Review of Current Literature. J Intern Med. 2019. doi: 10.1111/joim.12944.
Schranz D, Recla S, Malcic I, Kerst G, Mini N, Akintuerk H. Pulmonary artery banding in dilative cardiomyopathy of young children: review and protocol based on the current knowledge. Transl Pediatr. 2019;8(2):151-160. doi: 10.21037/tp.2019.04.09.
Carreira IM. Molecular characterization of dilated cardiomyopathy. Rev Port Cardiol. 2019; 38(2): 141-2. doi: 10.1016/j.repc.2019.02.002.
Yu J, Zeng C, Wang Y. Epigenetics in dilated cardiomyopathy. Curr Opin Cardiol. 2019; 34(3): 260-9. doi: 10.1097/HCO.0000000000000616.
Vashukova E. S. Modern approaches to the diagnosis of hereditary forms of thrombophilia. Rossiyskiy pediatricheskiy zhurnal. 2008; 5: 49-53.(In Russian)
Kapustin S.I. Inherited thrombophilia as a polygenic disease. Thromb. Haemost. 2006; 2: 24-34. (In Russian)
Momot A.P. Thrombotic state of readiness - the possibilities of modern diagnostics and prospects. Medical alphabet. 2013; 3: 70-6. (In Russian)
Khmelnickaya K, Shlyakhto EV, Sitnikova HY. Left ventricular aneurysm and endothelium-dependent hemostasis in patients with chronic heart failure. J Clin Lipid. 2008; 2(55): 395-6.
Lin KY, Kerur B, Witmer CM, Beslow LA, Licht DJ, Ichord RN, Kaufman BD. Thrombotic events in critically ill children with myocarditis. Cardiol Young. 2014; 24(5): 840-7.
Mene-Afejuku TO, Akinlonu A, Dumancas C, Lopez PD, Cardenas R, Sueldo C et al. Relationship between pulmonary hypertension and outcomes among patients with heart failure with reduced ejection fraction. Hosp Pract. 2019: 1-6. doi: 10.1080/21548331.2019.1628615.
Herath VC, Gentles TL, Skinner JR. Dilated cardiomyopathy in children: Review of all presentations to a children’s hospital over a 5-year period and the impact of family cardiac screening. J Paediatr Child Health. 2015; 51(6): 595-9. doi: 10.1111/jpc.12787.
Fadl S, Wåhlander H, Fall K, Cao Y, Sunnegårdh J. The highest mortality rates in childhood dilated cardiomyopathy occur during the first year after diagnosis. Acta Paediatr. 2018; 107(4): 672-7. doi: 10.1111/apa.14183.
Rubiś P, Totoń-Żurańska J, Wiśniowska-Śmiałek S, Kołton-Wróż M, Wołkow P, Wypasek E et al. Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy. Cardiol J. 2018; 25(6): 722-31. doi: 10.5603/CJ.a2017.0099.
Ahmad F, McNally EM, Ackerman MJ, Baty LC, Day SM, Kullo IJ et al. Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2019. doi: 10.1161/HCG.0000000000000054.
Elikowski W, Małek-Elikowska M, Fertała N, Zawodna M, Kruzel K. Fast apixaban-related resolution of left ventricular thrombi in a patient with dilated cardiomyopathy. Pol Merkur Lekarski. 2018; 44(259): 19-22.
Stoll VM, Hess AT, Rodgers CT, Bissell MM, Dyverfeldt P, Ebbers T et al. Left Ventricular Flow Analysis. Circ Cardiovasc Imaging. 2019; 12(5):e008130. doi: 10.1161/Circimaging.118.008130.
Berezovsky D. P. Molecular genetic basis of thrombophilia. Hematology and Transfusiology. 2008; 53(6): 36-41. (In Russian)
- Refbacks are not listed
Контент доступен под лицензией Creative Commons Attribution 3.0 License.